Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature
Objective: There is a scarcity of data from randomised controlled trials on the association of growth hormone (GH) with gonadotrophin-releasing hormone agonists in idiopathic short stature (ISS), although this off-label use is common. We aimed to test whether delaying pubertal progression could incr...
Main Authors: | Imane Benabbad, Myriam Rosilio, Maité Tauber, Emmanuel Paris, Anne Paulsen, Lovisa Berggren, Hiren Patel, Jean-Claude Carel |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2018-05-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | http://www.endocrineconnections.com/content/7/5/708.full |
Similar Items
-
Clonidine-stimulated growth hormone concentrations (cut-off values) measured by immunochemiluminescent assay (ICMA) in children and adolescents with short stature
by: Maria de Fátima Borges, et al.
Published: (2016-04-01) -
Pelvic Ultrasound Parameters of Long-Acting Depot Formulation of Leuprorelin in the Treatment of Idiopathic Central Precocious Puberty in Girls
by: Yang K, et al.
Published: (2021-04-01) -
A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin
by: Dohee Kim, et al.
Published: (2019-10-01) -
Efficacy and Safety of Domestic Leuprorelin in Girls with Idiopathic Central Precocious Puberty: A Multicenter, Randomized, Parallel, Controlled Trial
by: Wen-Jing Li, et al.
Published: (2015-01-01) -
Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
by: Rajni Sethi, et al.
Published: (2009-06-01)